Key Highlights
- Shares of Rocket Lab climbed 11.3%, reaching an intraday peak of $123.94 following Needham’s price target increase from $95 to $120 with a maintained Buy recommendation.
- Cantor Fitzgerald increased its target to $96 from $85, highlighting improved launch performance and expanding space operations.
- First-quarter revenue reached $200.35 million, marking a 63.4% year-over-year increase and surpassing analyst projections of $189.65 million.
- Earnings per share aligned with forecasts at -$0.07, while management upgraded second-quarter projections.
- Wall Street maintains a “Moderate Buy” consensus with an average target price of $91.79 across all analysts.
Shares of Rocket Lab USA (RKLB) experienced a powerful rally on Monday, advancing 11.3% after Needham & Company increased its price objective from $95 to $120 while reaffirming its Buy stance.
The aerospace stock touched an intraday peak of $123.94 before closing near $117.35. Trading activity exploded to approximately 53 million shares, more than doubling the typical daily volume of 23.3 million.
The upward momentum followed an impressive first-quarter financial report. Rocket Lab delivered revenue of $200.35 million in Q1, exceeding Wall Street’s estimate of $189.65 million and marking a robust 63.4% year-over-year expansion.
The company’s earnings per share registered at -$0.07, matching analyst projections precisely. This represents progress from the -$0.12 per share loss recorded in the same period last year, demonstrating significant improvement in the bottom line.
Management also elevated its second-quarter forecast, adding momentum to the bullish sentiment surrounding the stock.
Wall Street Analysts Boost Confidence
Cantor Fitzgerald added to the positive sentiment, increasing its price objective to $96 from $85 while maintaining an Overweight recommendation. The investment firm highlighted Rocket Lab’s operational excellence in launch activities and its broad service offerings, which include the Electron launch vehicle, the Haste hypersonic testing platform, and the forthcoming Neutron rocket system.
Stifel Nicolaus affirmed its Buy recommendation and elevated its target from $90 to $105. Bank of America established a $120 price target. Citigroup confirmed its Outperform rating at the end of last week.
Interestingly, despite these bullish projections from multiple analysts, the consensus average price target remains at $91.79, significantly trailing the current trading price. This discrepancy illustrates how rapidly the stock has appreciated.
Among analysts tracking RKLB, two assign Strong Buy ratings, ten recommend Buy, four maintain Hold positions, and one rates it as a Sell.
First-Quarter Performance Breakdown
Rocket Lab recorded a return on equity of -11.72% and a net margin of -26.87%, typical metrics for a developing aerospace enterprise.
The first-quarter outperformance stemmed from robust results across both launch operations and spacecraft manufacturing divisions. Cantor emphasized the company’s dual-location launch capabilities in New Zealand and the United States as a competitive differentiator.
Rocket Lab maintains a market capitalization of approximately $66.82 billion, a minimal debt-to-equity ratio of 0.02, and a current ratio of 4.47, indicating strong short-term financial flexibility.
The 50-day moving average sits at $72.88, while the 200-day moving average rests at $68.50, both substantially below present price levels.
Insider activity has tilted toward selling. Over the past three months, company insiders disposed of approximately 233,449 shares valued at more than $16.4 million. SVP Arjun Kampani executed sales in early March at an average price of $69.59, while Director Merline Saintil sold shares at $75.04. Corporate insiders collectively control approximately 8.4% of outstanding shares, with institutional investors commanding 71.78%.
Wall Street projects full-year earnings per share of -$0.22 for the current fiscal period.


